Hypoxia and cellular metabolism in tumour pathophysiology
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Cancer cells are optimised for growth and survival via an ability to outcompete normal cells in their microenvironment. Many of these advantageous cellular adaptations are promoted by the pathophysiological hypoxia that arises in solid tumours due to incomplete vascularisation. Tumour cells are thus faced with the challenge of an increased need for nutrients to support the drive for proliferation in the face of a diminished extracellular supply. Among the many modifications occurring in tumour cells, hypoxia inducible factors (HIFs) act as essential drivers of key pro‐survival pathways via the promotion of numerous membrane and cytosolic proteins. Here we focus our attention on two areas: the role of amino acid uptake and the handling of metabolic acid (CO 2/H+) production. We provide evidence for a number of hypoxia‐induced proteins that promote cellular anabolism and regulation of metabolic acid–base levels in tumour cells including amino‐acid transporters (LAT1), monocarboxylate transporters, and acid–base regulating carbonic anhydrases (CAs) and bicarbonate transporters (NBCs). Emphasis is placed on current work manipulating multiple CA isoforms and NBCs, which is at an interesting crossroads of gas physiology as they are regulated by hypoxia to contribute to the cellular handling of CO 2 and pH i regulation. Our research combined with others indicates that targeting of HIF‐regulated membrane proteins in tumour cells will provide promising future anti‐cancer therapeutic approaches and we suggest strategies that could be potentially used to enhance these tactics. image
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · cited 2×
“Indeed HIF1 was shown to induce pyruvate dehydrogenase kinase 1 (PDK1), thus inhibiting the conversion of pyruvate into acetyl-CoA by the pyruvate dehydrogenase complex (Kim et al. 2006; Papandreou et al. 2006).”
BackgroundMechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
Topalian, S. L., Taube, J. M., Anders, R. A., & Pardoll, D. M. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.36 · Cited by 2,733 · cited 1×
“Unfortunately, impressive advances in immunotherapy (PD-1, CTLA4, etc.) are thus far limited to a subset of patients ranging from 20–40% depending on the cancer type (for recent review see Topalian et al. 2016).”
BackgroundSemenza, G. L., & Wang, G. L. (1992) · Molecular and Cellular Biology · doi:10.1128/mcb.12.12.5447 · Cited by 2,617
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Nutrient-dependent mTORC1 Association with the ULK1–Atg13–FIP200 Complex Required for Autophagy
Hosokawa, N., Hara, T., Kaizuka, T., Kishi, C., Takamura, A., Miura, Y., Iemura, S.-I., Natsume, T., Takehana, K., Yamada, N., et al. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-12-1248 · Cited by 2,076 · cited 2×
“The Journal of Physiology C© 2017 The Physiological Society autophagy (Hosokawa et al. 2009; Koren et al. 2010; B’Chir et al. 2013), macropinocytosis (Palm et al. 2015) and the increased translation of specific stress response proteins such as AA transporters (Harding et al. 2003; Sato et al. 2004).”
BackgroundLDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells
Brand, A., Singer, K., Koehl, G. E., Kolitzus, M., Schoenhammer, G., Thiel, A., Matos, C., Bruss, C., Klobuch, S., Peter, K., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.08.011 · Cited by 2,039
Regulation of translation initiation by FRAP/mTOR
Gingras, A.-C., Raught, B., & Sonenberg, N. (2001) · Genes & Development · doi:10.1101/gad.887201 · Cited by 1,545 · cited 1×
“Indeed, in response to EAA starvation these pathways inhibit global protein synthesis (Gingras et al. 2001; Howell et al. 2013) and promote C© 2017 The Authors.”
BackgroundGeneral involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
Wang, G. L., & Semenza, G. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4304 · Cited by 1,468 · cited 1×
“…has been studied with a particular vigour in the last two decades following the discovery of the hypoxia-inducible transcription factor (HIF) (Semenza & Wang, 1992; Wang & Semenza, 1993a,b) and revelation of the extensive gene network that it regulates (Manalo et al. 2005; Schodel et al. 2011).”
BackgroundInfluentialSestrin2 is a leucine sensor for the mTORC1 pathway
Wolfson, R. L., Chantranupong, L., Saxton, R. A., Shen, K., Scaria, S. M., Cantor, J. R., & Sabatini, D. M. (2016) · Science · doi:10.1126/science.aab2674 · Cited by 1,306 · cited 2×
“2016) Moreover, a stable level of intracellular leucine is required in order to sustain activation of the master regulator of cell metabolism and growth, mTORC1 (Hara et al. 1998; Wolfson et al. 2016).”
BackgroundThe eIF2α/ATF4 pathway is essential for stress-induced autophagy gene expression
B’chir, W., Maurin, A.-C., Carraro, V., Averous, J., Jousse, C., Muranishi, Y., Parry, L., Stepien, G., Fafournoux, P., & Bruhat, A. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt563 · Cited by 1,162
Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1
Manalo, D. J., Rowan, A., Lavoie, T., Natarajan, L., Kelly, B. D., Ye, S. Q., Garcia, J. G. N., & Semenza, G. L. (2005) · Blood · doi:10.1182/blood-2004-07-2958 · Cited by 1,154
Nutrient-sensing mechanisms and pathways
Efeyan, A., Comb, W. C., & Sabatini, D. M. (2015) · Nature · doi:10.1038/nature14190 · Cited by 1,110
High-resolution genome-wide mapping of HIF-binding sites by ChIP-seq
Schödel, J., Oikonomopoulos, S., Ragoussis, J., Pugh, C. W., Ratcliffe, P. J., & Mole, D. R. (2011) · Blood · doi:10.1182/blood-2010-10-314427 · Cited by 724 · cited 2×
“Hypoxia has been studied with a particular vigour in the last two decades following the discovery of the hypoxia-inducible transcription factor (HIF) (Semenza & Wang, 1992; Wang & Semenza, 1993a,b) and revelation of the extensive gene network that it regulates (Manalo et al. 2005; Schodel et al. 2011).”
BackgroundInfluentialHypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH
Švastová, E., Hulı́ková, A., Rafajová, M., Zat'ovičová, M., Gibadulinová, A., Casini, A., Cecchi, A., Scozzafava, A., Supuran, C. T., Pastorek, J., et al. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.043 · Cited by 711
Neutralization of Tumor Acidity Improves Antitumor Responses to Immunotherapy
Pilon-Thomas, S., Kodumudi, K. N., El-Kenawi, A. E., Russell, S., Weber, A. M., Luddy, K., Damaghi, M., Wojtkowiak, J. W., Mulé, J. J., Ibrahim-Hashim, A., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1743 · Cited by 593 · cited 2×
“Evidence is being generated to support the counteraction of tumour acidosis via buffer therapy as an important mechanism to improve anti-tumour effects of immunotherapy, in particular T-cell activity (Pilon-Thomas et al. 2016).”
BackgroundTissue of origin dictates branched-chain amino acid metabolism in mutant Kras -driven cancers
Mayers, J. R., Torrence, M. E., Danai, L. V., Papagiannakopoulos, T., Davidson, S. M., Bauer, M. R., Lau, A. N., Ji, B. W., Dixit, P. D., Hosios, A. M., et al. (2016) · Science · doi:10.1126/science.aaf5171 · Cited by 582
BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1
Tönjes, M., Barbus, S., Park, Y. J., Wang, W., Schlotter, M., Lindroth, A. M., Pleier, S. V., Bai, A. H. C., Karra, D., Piro, R. M., et al. (2013) · Nature Medicine · doi:10.1038/nm.3217 · Cited by 486
The utilization of extracellular proteins as nutrients is suppressed by mTORC1
Palm, W., Park, Y., Wright, K., Pavlova, N. N., Tuveson, D. A., & Thompson, C. B. (2015) · Cell · doi:10.1016/j.cell.2015.06.017 · Cited by 457 · cited 2×
“The Journal of Physiology C© 2017 The Physiological Society autophagy (Hosokawa et al. 2009; Koren et al. 2010; B’Chir et al. 2013), macropinocytosis (Palm et al. 2015) and the increased translation of specific stress response proteins such as AA transporters (Harding et al. 2003; Sato et al. 2004).”
BackgroundActivity of the Monocarboxylate Transporter 1 Inhibitor AZD3965 in Small Cell Lung Cancer
Polański, R., Hodgkinson, C. L., Fusi, A., Nonaka, D., Priest, L., Kelly, P., Trapani, F., Bishop, P. W., White, A., Critchlow, S. E., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2270 · Cited by 378 · cited 2×
“A summary of an extensive body of work using a battery of techniques to disrupt MCT1, MCT4 and CD147 in isolation or combination has revealed that an impressive redundancy exists in the lactic acid excretory machinery to perpetuate cellular metabolism (Schneiderhan et al. 2009; Le Floch et al. 2011; Chiche et al. 2012…”
BackgroundHypoxia, cancer metabolism and the therapeutic benefit of targeting lactate/H(+) symporters
Marchiq, I., & Pouysségur, J. (2016) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1307-x · Cited by 300 · cited 2×
“…glycolysis reactivates oxidative phosphorylation, current efforts are focused on combined use of MCT inhibitors and mitochondrial inhibitors (phenformin) to achieve sufficient depletion of cellular energy stores to induce rapid tumour cell killing (Marchiq et al. 2015; Marchiq & Pouyssegur, 2016).”
BackgroundSelf-citationMcIntyre, A., Patiar, S., Wigfield, S., Li, J.-L., Ledaki, I., Turley, H., Leek, R., Snell, C., Gatter, K., Sly, W. S., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1877 · Cited by 239
Hansen, C. G., Ng, Y. L. D., Lam, W.-L. M., Plouffe, S. W., & Guan, K.-L. (2015) · Cell Research · doi:10.1038/cr.2015.140 · Cited by 212 · cited 2×
“This global LAT1 overexpression pattern in almost all cancers may be explained by the fact that its expression is under control of signalling pathways that are deregulated during carcinogenesis such as the Hippo (Hansen et al. 2015; Park et al. 2016) and Myc (Hayashi et al. 2012) pathways.”
Background
Cited by
Revisiting the Warburg effect: historical dogma versus current understanding
Vaupel, P., & Multhoff, G. (2021) · The Journal of Physiology · doi:10.1113/jp278810 · Cited by 830
Ždralević, M., Brand, A., Di Ianni, L., Dettmer, K., Reinders, J., Singer, K., Peter, K., Schnell, A., Bruss, C., Decking, S.-M., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004180 · Cited by 255
Self-citationHypoxia Signaling in Cancer: From Basics to Clinical Practice
Sebestyén, A., Kopper, L., Dankó, T., & Tímár, J. (2021) · Pathology and Oncology Research · doi:10.3389/pore.2021.1609802 · Cited by 110
Intratumoral hypoxia and mechanisms of immune evasion mediated by hypoxia-inducible factors
Semenza, G. L. (2021) · Physiology · doi:10.1152/physiol.00034.2020 · Cited by 64
Zhou, L., Cha, G., Chen, L., Yang, C., Xu, D., & Ge, M. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s203724 · Cited by 34
“Due to the rapid proliferation of tumor cells and the abnormality of tumor vessels in function and structure, the hypoxic areas widely exist in solid tumors.(15,16) By transcriptionally activating diverse targeting genes, HIF functions as a”
BackgroundRetracted
Metadata
- Authors
- Parks, S. K., Cormerais, Y., & Pouysségur, J.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2017-02-19
- Volume
- 595
- Issue
- 8
- Pages
- 2439-2450
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W2568192015
- Cited by
- 142
- References
- 22
- FWCI
- 4.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.